lixivaptan has been researched along with argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)- in 1 studies
| Studies (lixivaptan) | Trials (lixivaptan) | Recent Studies (post-2010) (lixivaptan) | Studies (argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-) | Trials (argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-) | Recent Studies (post-2010) (argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-) |
|---|---|---|---|---|---|
| 80 | 10 | 26 | 55 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Double-Cazanave, E; Garcia, C; Guillon, G; Maffrand, JP; Pascal, M; Raufaste, D; Serradeil-Le Gal, C | 1 |
1 other study(ies) available for lixivaptan and argipressin, deaminopenicillamine(1)-o-methyl-tyr(2)-
| Article | Year |
|---|---|
Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [H]-SR 121463.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Binding, Competitive; Cattle; CHO Cells; Cricetinae; Dogs; Haplorhini; Homeostasis; Humans; Kidney; Kinetics; Morpholines; Rabbits; Radioligand Assay; Rats; Spiro Compounds; Swine; Tritium; Vasopressins; Water-Electrolyte Balance | 2000 |